CTRI/2023/02/050006尚未招募未知
A descriptive study to assess the impact of post COVID conditions on quality of life among employees of selected institutes of MAHE, Manipal, Udupi district.
Anamika Das0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.The study will be delimited to only those who tested positive for COVID19 infection
- •2.The study will be delimited to employees of selected institutions of MAHE, Manipal.
- •3.The study will be delimited to only those who voluntarily disclose their COVID status and willingly participates in the study.
排除标准
- •1.Employees who donâ??t want to participate in the study voluntarily.
- •2.Employees who cannot read and write English.
- •3.Out sourced employees of MAHE.
研究者
相似试验
招募中
2 期
A prospective study to investigate the effect of CBM558 combined with pembrolizumab on gut microbiota and prognosis in patients with advanced urothelial carcinoma.JPRN-jRCTs031220689Taguchi Satoru30
尚未招募
不适用
To assess post Covid symptoms in patient admitted in Covid care centre at NISCTRI/2022/02/040032ational Institute of Siddha
招募中
Unknown
Observational Study of the Effect of Cardiac Rehabilitaion on QOL in Patients with AMIacute myocardial infarctionJPRN-jRCT1050230042Kondo Takumi200
进行中（未招募）
不适用
A phase IIa study to characterize the effects of CCL2 inhibition with the Spiegelmer® NOX-E36 in patients with type 2 diabetes mellitus and albuminuriadiabetes mellitus type II and albuminuriaMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2011-005710-11-DEOXXON Pharma AG75
进行中（未招募）
不适用
A phase IIa study to characterize the effects of CCL2 inhibition with the Spiegelmer® NOX-E36 in patients with type 2 diabetes mellitus and albuminuriadiabetes mellitus type II and albuminuriaMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2011-005710-11-CZOXXON Pharma AG75